| Line Item | 2025-03-31 | Y/Y |
|---|---|---|
| R&D Expense | $662K | -72.4% |
| SG&A Expense | $1.2M | +9.2% |
| Operating Income | -$1.8M | +47.3% |
| Interest Expense | $320K | +296.9% |
| Income Tax | -$3K | — |
| Net Income | -$2.5M | +28.7% |
| Line Item | 2025-03-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $653K | — |
| Current Assets | $653K | — |
| Total Assets | $1.3M | +64.8% |
| Current Liabilities | $4.9M | +28.1% |
| Long-term Debt | $184K | +0.0% |
| Total Liabilities | $5.4M | +12.2% |
| Stockholders' Equity | -$4.2M | -2.3% |
| Line Item | 2025-03-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$1.6M | -255.2% |
| Investing Cash Flow | -$1K | +80.5% |
| Financing Cash Flow | $2.3M | +392.2% |